VolitionRx Limited announced that it has issued unsecured loan for gross proceeds of ?2.5 million on December 5, 2023. The unsecured loan bears interest at a rate of approximately 8% per year and has a stated maturity date of December 31, 2028. Subject to certain conditions, the loan can be drawn down in three tranches at Belgian Volition?s election on or prior to June 30, 2025, with ?1.5 million available immediately, ?0.5 million available from June 1, 2024 and the final ?0.5 million available from March 1, 2025.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9137 USD | +2.65% | +48.33% | +27.43% |
Apr. 26 | VolitionRx Limited Announces Board Changes | CI |
Apr. 23 | VolitionRx Limited Launches In-Clinic in U.S. and Europe Through Antech | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.43% | 74.99M | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 383M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- VolitionRx Limited announced that it has received ?2.5 million in funding